Loading…

A multimodal neuroimaging study of brain abnormalities and clinical correlates in post treatment Lyme disease

Lyme disease is the most common vector-borne infectious disease in the United States. Post-treatment Lyme disease (PTLD) is a condition affecting 10–20% of patients in which symptoms persist despite antibiotic treatment. Cognitive complaints are common among those with PTLD, suggesting that brain ch...

Full description

Saved in:
Bibliographic Details
Published in:PloS one 2022-01, Vol.17 (10)
Main Authors: Cherie L. Marvel, Kylie H. Alm, Deeya Bhattacharya, Alison W. Rebman, Arnold Bakker, Owen P. Morgan, Jason A. Creighton, Erica A. Kozero, Arun Venkatesan, Prianca A. Nadkarni, John N. Aucott
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue 10
container_start_page
container_title PloS one
container_volume 17
creator Cherie L. Marvel
Kylie H. Alm
Deeya Bhattacharya
Alison W. Rebman
Arnold Bakker
Owen P. Morgan
Jason A. Creighton
Erica A. Kozero
Arun Venkatesan
Prianca A. Nadkarni
John N. Aucott
description Lyme disease is the most common vector-borne infectious disease in the United States. Post-treatment Lyme disease (PTLD) is a condition affecting 10–20% of patients in which symptoms persist despite antibiotic treatment. Cognitive complaints are common among those with PTLD, suggesting that brain changes are associated with the course of the illness. However, there has been a paucity of evidence to explain the cognitive difficulties expressed by patients with PTLD. This study administered a working memory task to a carefully screened group of 12 patients with well-characterized PTLD and 18 healthy controls while undergoing functional MRI (fMRI). A subset of 12 controls and all 12 PTLD participants also received diffusion tensor imaging (DTI) to measure white matter integrity. Clinical variables were also assessed and correlated with these multimodal MRI findings. On the working memory task, the patients with PTLD responded more slowly, but no less accurately, than did controls. FMRI activations were observed in expected regions by the controls, and to a lesser extent, by the PTLD participants. The PTLD group also hypoactivated several regions relevant to the task. Conversely, novel regions were activated by the PTLD group that were not observed in controls, suggesting a compensatory mechanism. Notably, three activations were located in white matter of the frontal lobe. DTI measures applied to these three regions of interest revealed that higher axial diffusivity correlated with fewer cognitive and neurological symptoms. Whole-brain DTI analyses revealed several frontal lobe regions in which higher axial diffusivity in the patients with PTLD correlated with longer duration of illness. Together, these results show that the brain is altered by PTLD, involving changes to white matter within the frontal lobe. Higher axial diffusivity may reflect white matter repair and healing over time, rather than pathology, and cognition appears to be dynamically affected throughout this repair process.
format article
fullrecord <record><control><sourceid>doaj</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_fbb5f278ff6b434e81f72a57ec81a45f</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_fbb5f278ff6b434e81f72a57ec81a45f</doaj_id><sourcerecordid>oai_doaj_org_article_fbb5f278ff6b434e81f72a57ec81a45f</sourcerecordid><originalsourceid>FETCH-doaj_primary_oai_doaj_org_article_fbb5f278ff6b434e81f72a57ec81a45f3</originalsourceid><addsrcrecordid>eNqtjUtKBTEQRYMg-PzsoTbwoP_dDkUUBYfOQyWpNPXI51FJD3r3NuISHF043HPvjTq1z313nrqmv1P3pVyaZuyXaTqp-AJxC5Vjdhgg0SaZI66cVih1cztkD0aQE6BJWSIGrkwFMDmwgRPbQ7NZhALWgx_Fay4VqhDWSKnC1x4JHBfCQo_q1mMo9PSXD-rz_e379ePsMl70VY5r2XVG1r8gy6pRKttA2hsz-m5evJ_M0A-0tH7ucJzJLi0Oo-__c-sHsONk-A</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>A multimodal neuroimaging study of brain abnormalities and clinical correlates in post treatment Lyme disease</title><source>Open Access: PubMed Central</source><source>ProQuest - Publicly Available Content Database</source><creator>Cherie L. Marvel ; Kylie H. Alm ; Deeya Bhattacharya ; Alison W. Rebman ; Arnold Bakker ; Owen P. Morgan ; Jason A. Creighton ; Erica A. Kozero ; Arun Venkatesan ; Prianca A. Nadkarni ; John N. Aucott</creator><creatorcontrib>Cherie L. Marvel ; Kylie H. Alm ; Deeya Bhattacharya ; Alison W. Rebman ; Arnold Bakker ; Owen P. Morgan ; Jason A. Creighton ; Erica A. Kozero ; Arun Venkatesan ; Prianca A. Nadkarni ; John N. Aucott</creatorcontrib><description>Lyme disease is the most common vector-borne infectious disease in the United States. Post-treatment Lyme disease (PTLD) is a condition affecting 10–20% of patients in which symptoms persist despite antibiotic treatment. Cognitive complaints are common among those with PTLD, suggesting that brain changes are associated with the course of the illness. However, there has been a paucity of evidence to explain the cognitive difficulties expressed by patients with PTLD. This study administered a working memory task to a carefully screened group of 12 patients with well-characterized PTLD and 18 healthy controls while undergoing functional MRI (fMRI). A subset of 12 controls and all 12 PTLD participants also received diffusion tensor imaging (DTI) to measure white matter integrity. Clinical variables were also assessed and correlated with these multimodal MRI findings. On the working memory task, the patients with PTLD responded more slowly, but no less accurately, than did controls. FMRI activations were observed in expected regions by the controls, and to a lesser extent, by the PTLD participants. The PTLD group also hypoactivated several regions relevant to the task. Conversely, novel regions were activated by the PTLD group that were not observed in controls, suggesting a compensatory mechanism. Notably, three activations were located in white matter of the frontal lobe. DTI measures applied to these three regions of interest revealed that higher axial diffusivity correlated with fewer cognitive and neurological symptoms. Whole-brain DTI analyses revealed several frontal lobe regions in which higher axial diffusivity in the patients with PTLD correlated with longer duration of illness. Together, these results show that the brain is altered by PTLD, involving changes to white matter within the frontal lobe. Higher axial diffusivity may reflect white matter repair and healing over time, rather than pathology, and cognition appears to be dynamically affected throughout this repair process.</description><identifier>EISSN: 1932-6203</identifier><language>eng</language><publisher>Public Library of Science (PLoS)</publisher><ispartof>PloS one, 2022-01, Vol.17 (10)</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids></links><search><creatorcontrib>Cherie L. Marvel</creatorcontrib><creatorcontrib>Kylie H. Alm</creatorcontrib><creatorcontrib>Deeya Bhattacharya</creatorcontrib><creatorcontrib>Alison W. Rebman</creatorcontrib><creatorcontrib>Arnold Bakker</creatorcontrib><creatorcontrib>Owen P. Morgan</creatorcontrib><creatorcontrib>Jason A. Creighton</creatorcontrib><creatorcontrib>Erica A. Kozero</creatorcontrib><creatorcontrib>Arun Venkatesan</creatorcontrib><creatorcontrib>Prianca A. Nadkarni</creatorcontrib><creatorcontrib>John N. Aucott</creatorcontrib><title>A multimodal neuroimaging study of brain abnormalities and clinical correlates in post treatment Lyme disease</title><title>PloS one</title><description>Lyme disease is the most common vector-borne infectious disease in the United States. Post-treatment Lyme disease (PTLD) is a condition affecting 10–20% of patients in which symptoms persist despite antibiotic treatment. Cognitive complaints are common among those with PTLD, suggesting that brain changes are associated with the course of the illness. However, there has been a paucity of evidence to explain the cognitive difficulties expressed by patients with PTLD. This study administered a working memory task to a carefully screened group of 12 patients with well-characterized PTLD and 18 healthy controls while undergoing functional MRI (fMRI). A subset of 12 controls and all 12 PTLD participants also received diffusion tensor imaging (DTI) to measure white matter integrity. Clinical variables were also assessed and correlated with these multimodal MRI findings. On the working memory task, the patients with PTLD responded more slowly, but no less accurately, than did controls. FMRI activations were observed in expected regions by the controls, and to a lesser extent, by the PTLD participants. The PTLD group also hypoactivated several regions relevant to the task. Conversely, novel regions were activated by the PTLD group that were not observed in controls, suggesting a compensatory mechanism. Notably, three activations were located in white matter of the frontal lobe. DTI measures applied to these three regions of interest revealed that higher axial diffusivity correlated with fewer cognitive and neurological symptoms. Whole-brain DTI analyses revealed several frontal lobe regions in which higher axial diffusivity in the patients with PTLD correlated with longer duration of illness. Together, these results show that the brain is altered by PTLD, involving changes to white matter within the frontal lobe. Higher axial diffusivity may reflect white matter repair and healing over time, rather than pathology, and cognition appears to be dynamically affected throughout this repair process.</description><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNqtjUtKBTEQRYMg-PzsoTbwoP_dDkUUBYfOQyWpNPXI51FJD3r3NuISHF043HPvjTq1z313nrqmv1P3pVyaZuyXaTqp-AJxC5Vjdhgg0SaZI66cVih1cztkD0aQE6BJWSIGrkwFMDmwgRPbQ7NZhALWgx_Fay4VqhDWSKnC1x4JHBfCQo_q1mMo9PSXD-rz_e379ePsMl70VY5r2XVG1r8gy6pRKttA2hsz-m5evJ_M0A-0tH7ucJzJLi0Oo-__c-sHsONk-A</recordid><startdate>20220101</startdate><enddate>20220101</enddate><creator>Cherie L. Marvel</creator><creator>Kylie H. Alm</creator><creator>Deeya Bhattacharya</creator><creator>Alison W. Rebman</creator><creator>Arnold Bakker</creator><creator>Owen P. Morgan</creator><creator>Jason A. Creighton</creator><creator>Erica A. Kozero</creator><creator>Arun Venkatesan</creator><creator>Prianca A. Nadkarni</creator><creator>John N. Aucott</creator><general>Public Library of Science (PLoS)</general><scope>DOA</scope></search><sort><creationdate>20220101</creationdate><title>A multimodal neuroimaging study of brain abnormalities and clinical correlates in post treatment Lyme disease</title><author>Cherie L. Marvel ; Kylie H. Alm ; Deeya Bhattacharya ; Alison W. Rebman ; Arnold Bakker ; Owen P. Morgan ; Jason A. Creighton ; Erica A. Kozero ; Arun Venkatesan ; Prianca A. Nadkarni ; John N. Aucott</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-doaj_primary_oai_doaj_org_article_fbb5f278ff6b434e81f72a57ec81a45f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cherie L. Marvel</creatorcontrib><creatorcontrib>Kylie H. Alm</creatorcontrib><creatorcontrib>Deeya Bhattacharya</creatorcontrib><creatorcontrib>Alison W. Rebman</creatorcontrib><creatorcontrib>Arnold Bakker</creatorcontrib><creatorcontrib>Owen P. Morgan</creatorcontrib><creatorcontrib>Jason A. Creighton</creatorcontrib><creatorcontrib>Erica A. Kozero</creatorcontrib><creatorcontrib>Arun Venkatesan</creatorcontrib><creatorcontrib>Prianca A. Nadkarni</creatorcontrib><creatorcontrib>John N. Aucott</creatorcontrib><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cherie L. Marvel</au><au>Kylie H. Alm</au><au>Deeya Bhattacharya</au><au>Alison W. Rebman</au><au>Arnold Bakker</au><au>Owen P. Morgan</au><au>Jason A. Creighton</au><au>Erica A. Kozero</au><au>Arun Venkatesan</au><au>Prianca A. Nadkarni</au><au>John N. Aucott</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A multimodal neuroimaging study of brain abnormalities and clinical correlates in post treatment Lyme disease</atitle><jtitle>PloS one</jtitle><date>2022-01-01</date><risdate>2022</risdate><volume>17</volume><issue>10</issue><eissn>1932-6203</eissn><abstract>Lyme disease is the most common vector-borne infectious disease in the United States. Post-treatment Lyme disease (PTLD) is a condition affecting 10–20% of patients in which symptoms persist despite antibiotic treatment. Cognitive complaints are common among those with PTLD, suggesting that brain changes are associated with the course of the illness. However, there has been a paucity of evidence to explain the cognitive difficulties expressed by patients with PTLD. This study administered a working memory task to a carefully screened group of 12 patients with well-characterized PTLD and 18 healthy controls while undergoing functional MRI (fMRI). A subset of 12 controls and all 12 PTLD participants also received diffusion tensor imaging (DTI) to measure white matter integrity. Clinical variables were also assessed and correlated with these multimodal MRI findings. On the working memory task, the patients with PTLD responded more slowly, but no less accurately, than did controls. FMRI activations were observed in expected regions by the controls, and to a lesser extent, by the PTLD participants. The PTLD group also hypoactivated several regions relevant to the task. Conversely, novel regions were activated by the PTLD group that were not observed in controls, suggesting a compensatory mechanism. Notably, three activations were located in white matter of the frontal lobe. DTI measures applied to these three regions of interest revealed that higher axial diffusivity correlated with fewer cognitive and neurological symptoms. Whole-brain DTI analyses revealed several frontal lobe regions in which higher axial diffusivity in the patients with PTLD correlated with longer duration of illness. Together, these results show that the brain is altered by PTLD, involving changes to white matter within the frontal lobe. Higher axial diffusivity may reflect white matter repair and healing over time, rather than pathology, and cognition appears to be dynamically affected throughout this repair process.</abstract><pub>Public Library of Science (PLoS)</pub><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier EISSN: 1932-6203
ispartof PloS one, 2022-01, Vol.17 (10)
issn 1932-6203
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_fbb5f278ff6b434e81f72a57ec81a45f
source Open Access: PubMed Central; ProQuest - Publicly Available Content Database
title A multimodal neuroimaging study of brain abnormalities and clinical correlates in post treatment Lyme disease
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T12%3A09%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-doaj&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20multimodal%20neuroimaging%20study%20of%20brain%20abnormalities%20and%20clinical%20correlates%20in%20post%20treatment%20Lyme%20disease&rft.jtitle=PloS%20one&rft.au=Cherie%20L.%20Marvel&rft.date=2022-01-01&rft.volume=17&rft.issue=10&rft.eissn=1932-6203&rft_id=info:doi/&rft_dat=%3Cdoaj%3Eoai_doaj_org_article_fbb5f278ff6b434e81f72a57ec81a45f%3C/doaj%3E%3Cgrp_id%3Ecdi_FETCH-doaj_primary_oai_doaj_org_article_fbb5f278ff6b434e81f72a57ec81a45f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true